The cell surface receptor TNFRSF10B (DR5, TRAIL-R2) is commonly overexpressed on the surface of cancer cells, and in preclinical studies, its ligand TNF-related apoptosis-inducing ligand (TRAIL)-activated apoptosis selectively in cancer versus normal cells (1). Here, TNFRSF10B is linked to cancer.